MktsMarkets

TransMedics Group, Inc.
NASDAQ: TMDXKey statistics
TMDX News
Stories mentioning TMDX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 173,933 | 160,764 | 143,823 | 157,370 | 143,537 | 121,624 | 108,761 | 114,305 |
| Cost of Goods Sold | 72,772 | 67,350 | 59,248 | 60,781 | 55,309 | 49,611 | 47,916 | 45,044 |
| Gross Profit | 101,161 | 93,414 | 84,575 | 96,589 | 88,228 | 72,013 | 60,845 | 69,261 |
| Operating Expenses | ||||||||
| Research & Development | 24,879 | 20,701 | 15,260 | 15,934 | 17,160 | 16,464 | 14,266 | 13,858 |
| Sales General & Admin | 62,985 | 51,440 | 46,015 | 44,088 | 43,625 | 46,905 | 42,656 | 42,895 |
| Total Operating Expenses | 87,864 | 72,141 | 61,275 | 60,022 | 60,785 | 63,369 | 56,922 | 56,753 |
| Operating Income (Loss) | 13,297 | 21,273 | 23,300 | 36,567 | 27,443 | 8,644 | 3,923 | 12,508 |
| Interest Income | ||||||||
| Interest Expense | 3,623 | |||||||
| Other Expense | ||||||||
| Pretax Income | 8,485 | 21,633 | 23,031 | 36,182 | 26,676 | 6,989 | 4,245 | 12,153 |
| Tax Provision | 1,170 | (83,750) | (1,288) | 1,275 | 994.00 | 132.00 | 29.00 | (41.00) |
| Net Income (Loss) | 7,315 | 105,383 | 24,319 | 34,907 | 25,682 | 6,857 | 4,216 | 12,194 |
| Earnings Per Share (Basic) | 0.21 | 3.10 | 0.71 | 1.03 | 0.76 | 0.21 | 0.13 | 0.37 |
| Earnings Per Share (Diluted) | 0.20 | 2.60 | 0.66 | 0.92 | 0.70 | 0.19 | 0.12 | 0.35 |
| Weighted Average Shares Outstanding (Basic) | 34,384 | 33,993 | 34,112 | 33,913 | 33,722 | 33,230 | 33,441 | 33,120 |
| Weighted Average Shares Outstanding (Diluted) | 36,194 | 40,541 | 40,748 | 40,559 | 39,914 | 35,217 | 35,684 | 35,288 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About TMDX
TransMedics Group, Inc. (NASDAQ: TMDX) is a stock listed on the Nasdaq Stock Market under the ticker symbol TMDX. It last traded at $92.01 (Nov 11, 2026, 4:00 PM ET), up 1.2% on the day. That gives TransMedics a market capitalisation of $3.2B and a price-to-earnings ratio of 21.3.
Over the past 52 weeks TMDX has traded between $60.10 and $156.00.
Revenue for the quarter ended Mar 31, 2026 was $173.9M; net income $7.3M. Revenue was up 21.2% from $143.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $173.9M | $7.3M | 4.2% |
| Dec 31, 2025 | $160.8M | $105.4M | 65.6% |
| Sep 30, 2025 | $143.8M | $24.3M | 16.9% |
| Jun 30, 2025 | $157.4M | $34.9M | 22.2% |
From TransMedics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…